• Profile
Close

Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD

Clinical Journal of the American Society of Nephrology Nov 11, 2017

Bushinsky DA, et al. - TRC101 (a novel, sodium-free, nonabsorbed hydrochloric acid binder) was assessed for efficacy and safety in increasing serum bicarbonate in patients with CKD and metabolic acidosis. Among study participants, significantly increased levels of serum bicarbonate were evident as a result of treatment with TRC101. Data also demonstrated the safety of TRC101 in these patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay